Results 221 to 230 of about 138,072 (341)

Beyond the stomach: early bone metastases revealing canine gastric adenocarcinoma

Journal of Small Animal Practice, EarlyView.
G. d. S. Schiavi, C. Y. A. Kawabata, J. V. P. Campos, L. N. Lima, A. M. A. Abranches, L. L. Patente, V. D. Laranjeira, V. Nowosh, J. V. de Assis, A. J. S. de Souza   +9 more
wiley   +1 more source

Unveiling a New Link: Cholesterol Deficiency in Smith–Lemli–Opitz and Niemann–Pick C as a Driver of Ciliopathies

American Journal of Medical Genetics Part A, Volume 200, Issue 6, Page 1179-1191, June 2026.
ABSTRACT The ciliopathies are a group of genetic disorders caused by defective function of either the primary cilia (a large number) or the motile cilia (a much smaller number). These have been defined as diseases with mutations in genes encoding individual ciliary or cilia‐associated proteins.
Robert P. Erickson, Maria Teresa Fiorenza   +1 more
wiley   +1 more source

Analytical cohort study on splenomegaly and cytopenias in myeloproliferative disorders. [PDF]

Bioinformation
Sinha S, Rajan VP, Nair AU, Jakka AP, Chandrasekaran SP.   +4 more
europepmc   +1 more source

De novo mutations in ANK1 and SPTB cause hereditary spherocytosis: three case reports and literature review. [PDF]

Ann Hematol
Qin Y, Lu L, Huang X, Li W, Qin Y, Tang S, Wei S.   +6 more
europepmc   +1 more source

Age‐Dependent Differences in Canakinumab Safety: A Comprehensive Pharmacovigilance Analysis Using the FAERS Database

Pharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.
ABSTRACT While the efficacy of canakinumab, an anti‐interleukin‐1β monoclonal antibody, is well‐established, its safety profile, particularly across different age groups, remains inadequately explored. Using the FDA Adverse Event Reporting System (FAERS) database, this study evaluated postmarketing safety by analyzing adverse event (AE) reports from ...
Youyang Wang, Ngasin Lam, Xiaoming Huang, Yang Jiao   +3 more
wiley   +1 more source

Prefibrotic myelofibrosis: recent updates in diagnosis, prognostication, and management 2026. [PDF]

Ther Adv Hematol
Al-Zubaidi N, Makris K, Sriskandarajah P.   +2 more
europepmc   +1 more source

Tissue‐retained needles in people who inject drugs: A systematic review of case reports and series on clinical presentations, complications and management

Addiction, Volume 121, Issue 6, Page 1381-1397, June 2026.
Abstract Background and aims Tissue‐retained needles from intravenous drug use can cause rare but severe complications, ranging from local to systemic infections to needle embolization. Due to the limited evidence and the lack of epidemiological studies on the issue, we systematically reviewed the literature focusing on case reports and case series on ...
Heidi Laukkala, Anna Nevalainen, Irina Rinta‐Kiikka, Samuel Heikkilä, Sisu Kiuru, Markku Sumanen, Otso Arponen, Olli Nevalainen   +7 more
wiley   +1 more source

Visceral Leishmaniasis in Somalia: Diagnosis and Management of a Classic Case in a Resource-Limited Endemic Setting. [PDF]

Clin Case Rep
Hussein AN, Ali AO, Ahmed RZ, Abdirahman SM, Abdiwahab AD.   +4 more
europepmc   +1 more source

Diagnosing Systemic Mastocytosis: State of the Art

International Journal of Laboratory Hematology, Volume 48, Issue 3, Page 551-560, June 2026.
ABSTRACT With the advent of effective multikinase and selective tyrosine kinase inhibitors in systemic mastocytosis, diagnosing this rare disease has been critical to improving patient morbidity and mortality. This state‐of‐the‐art review interprets the international diagnostic criteria, including differences between the WHO 5th edition classification ...
Anton Rets, Tracy I. George
wiley   +1 more source

Evaluation of Sharpunkha's Efficacy in Splenomegaly- A Research Report.

J Pharm Bioallied Sci
Gurmule RK, Sawarkar GR.
europepmc   +1 more source